BEAM
Price
$30.43
Change
-$2.71 (-8.18%)
Updated
Feb 21 closing price
Capitalization
2.52B
10 days until earnings call
PYXS
Price
$1.28
Change
-$0.08 (-5.88%)
Updated
Feb 21 closing price
Capitalization
76.12M
26 days until earnings call
Ad is loading...

BEAM vs PYXS

Header iconBEAM vs PYXS Comparison
Open Charts BEAM vs PYXSBanner chart's image
Beam Therapeutics
Price$30.43
Change-$2.71 (-8.18%)
Volume$1.88M
Capitalization2.52B
Pyxis Oncology
Price$1.28
Change-$0.08 (-5.88%)
Volume$635.02K
Capitalization76.12M
BEAM vs PYXS Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PYXS commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PYXS is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (BEAM: $33.14 vs. PYXS: $1.36)
Brand notoriety: BEAM and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 102% vs. PYXS: 53%
Market capitalization -- BEAM: $2.52B vs. PYXS: $76.12M
BEAM [@Biotechnology] is valued at $2.52B. PYXS’s [@Biotechnology] market capitalization is $76.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than PYXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • PYXS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both BEAM and PYXS are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а +15.83% price change this week, while PYXS (@Biotechnology) price change was +4.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

PYXS is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.52B) has a higher market cap than PYXS($76.1M). BEAM YTD gains are higher at: 33.629 vs. PYXS (-12.821). PYXS has higher annual earnings (EBITDA): -64.04M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. PYXS (145M). PYXS has less debt than BEAM: PYXS (20.5M) vs BEAM (162M). BEAM has higher revenues than PYXS: BEAM (350M) vs PYXS (16.1M).
BEAMPYXSBEAM / PYXS
Capitalization2.52B76.1M3,311%
EBITDA-160.83M-64.04M251%
Gain YTD33.629-12.821-262%
P/E RatioN/AN/A-
Revenue350M16.1M2,174%
Total Cash926M145M639%
Total Debt162M20.5M790%
TECHNICAL ANALYSIS
Technical Analysis
BEAMPYXS
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEGAX14.05N/A
N/A
abrdn Emerging Markets A
DIECX39.81N/A
N/A
BNY Mellon International Core Equity C
FTVFX34.83N/A
N/A
Fidelity Advisor Value M
BEXFX15.70N/A
N/A
Baron Emerging Markets Retail
FMCMX44.90N/A
N/A
American Funds AMCAP 529-F-3

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+0.74%
KURA - PYXS
59%
Loosely correlated
-1.69%
CTMX - PYXS
39%
Loosely correlated
+1.91%
BEAM - PYXS
38%
Loosely correlated
-2.79%
DNLI - PYXS
38%
Loosely correlated
-2.88%
ABOS - PYXS
36%
Loosely correlated
-1.43%
More